Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model

Publisher： John Wiley & Sons Inc

E-ISSN： 1742-7843|117|5|335-339

ISSN： 1742-7835

Source： BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol.117, Iss.5, 2015-11, pp. : 335-339

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of the Magenstrasse and Mill Operation for Obesity on Plasma Plasminogen Activator Inhibitor Type 1, Tissue Plasminogen Activator, Fibrinogen and Insulin

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 40-43

Karger

Access to resources Recommend Favorite

Successful treatment of pediatric stroke with recombinant tissue plasminogen activator (rt-PA): a case report and review of the literature

By  

Canadian Journal of Emergency Medicine, Vol. 10, Iss. 6, 2008-11 ,pp. : 575-578

Cambridge University Press

Access to resources Recommend Favorite

Tissue plasminogen activator for acute ischemic stroke: Is the CAEP Position Statement too negative?

By  

Canadian Journal of Emergency Medicine, Vol. 3, Iss. 3, 2001-07 ,pp. : 183-185

Cambridge University Press

Access to resources Recommend Favorite

Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years

By  

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 16, Iss. 7, 2016-07 ,pp. : 843-849

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Intracoronary Tissue-Type Plasminogen Activator Treatment in Kawasaki Disease and Acute Myocardial Infarction

By  

Cardiology, Vol. 94, Iss. 1, 2000-11 ,pp. : 52-57

Karger

Access to resources Recommend Favorite